Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Suryaningtyas Margi Utami"'
Publikováno v:
AIP Conference Proceedings.
Sodium Glucose Co-transporter 2 (SGLT2) inhibitor is an alternative pharmacology therapy for patients with type 2 diabetes mellitus who are unresponsive to metformin as the standard therapy. SGLT2 is a protein transporter that reabsorbs 90% of glucos
Autor:
Mila Ulfia, Brian Wasita, Dono Indarto, Devi Trisna Ramadhani, Suryaningtyas Margi Utami, Rafi Amanda Rezkia Amradani
Publikováno v:
IOP Conference Series: Materials Science and Engineering. 546:062023
Sodium Glucose Co-Transporter 2 (SGLT2) inhibitor is the second line of type 2 diabetes mellitus (T2DM) treatment. From in silico and in vitro studies, ellagic acid in pomegranate fruits has a similar effect to the SGLT2 inhibitor. This study aimed t
Autor:
Devi Trisna Ramadhani, Rafi Amanda Rezkia Amradani, Mila Ulfia, Suryaningtyas Margi Utami, Dono Indarto, Brian Wasita
Publikováno v:
IOP Conference Series: Materials Science & Engineering; Jul2019, Vol. 546 Issue 6, p1-1, 1p